Pembrolizumab Followed by Chemotherapy for the Treatment of Patients With Classical Hodgkin Lymphoma
Clinical trial NCT06164275 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06164275
- Sponsor
- Northwestern University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-06
- Primary completion
- 2025-07-15
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.